Cornell Pochily Investment Advisors, Inc. Bristol Myers Squibb CO Transaction History
Cornell Pochily Investment Advisors, Inc.
- $301 Million
- Q2 2025
A detailed history of Cornell Pochily Investment Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornell Pochily Investment Advisors, Inc. holds 15,336 shares of BMY stock, worth $704,689. This represents 0.24% of its overall portfolio holdings.
Number of Shares
15,336
Previous 15,186
0.99%
Holding current value
$704,689
Previous $926,000
23.43%
% of portfolio
0.24%
Previous 0.33%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.79 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...